Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,246.93
-8.4700-0.67%
Post-market: 1,249.602.67+0.21%19:31 EDT
Volume:1.67M
Turnover:2.07B
Market Cap:1.18T
PE:41.86
High:1,262.14
Open:1,262.14
Low:1,230.95
Close:1,255.40
52wk High:1,292.65
52wk Low:694.23
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.60
T/O Rate:0.18%
Dividend:6.69
Dividend Rate:0.54%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:34.80
PE(LYR):54.33

Loading ...

Eli Lilly Stock (LLY) Gets a Boost as Eczema Treatment Is Approved in Canada

TIPRANKS
·
Jul 08

Eli Lilly is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

Lilly Canada Receives Long-awaited Ebglyss® Cda-amc Recommendation as Well as Pcpa Loi for Atopic Dermatitis (eczema)

THOMSON REUTERS
·
Jul 08

Eli Lilly price target raised to $1,347 from $1,344 at Morgan Stanley

TIPRANKS
·
Jul 08

RBC Capital Adjusts Eli Lilly Price Target to $1,500 From $1,250, Maintains Outperform Rating

MT Newswires Live
·
Jul 08

Eli Lilly : RBC Raises Target Price to $1,500 from $1,250

THOMSON REUTERS
·
Jul 08

It Can Take as Little as 5 Minutes Online to Get Prescribed a GLP-1 for Weight Loss. Why That's Risky.

Dow Jones
·
Jul 08

Race to Launch Weight-loss Pills Heats up as Smaller Players Advance

Reuters
·
Jul 08

Eli Lilly Seen Raising Guidance on Continued GLP-1 Growth

Dow Jones
·
Jul 07

Weight-loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Jul 07

Eli Lilly Shares up 3%; JP Morgan Lifts PT

THOMSON REUTERS
·
Jul 07

J.p.morgan Lifts Eli Lilly PT; Expects Another 2026 Forecast Raise

Reuters
·
Jul 07

Eli Lilly and Co Stock (LLY) Moved Up by 3.08% on Jul 7: Facts Behind the Movement

TradingKey
·
Jul 07

Movement Alert|Eli Lilly Rises 3.36% in Regular Trading, Multiple Banks Raise Target Prices as Mounjaro Wins Pediatric Approval in Canada

Market Focus
·
Jul 07

Pharma Stocks Rally: Eli Lilly, J&J Hit Record Highs; CRNX Surges Almost 100%

Tiger Newspress
·
Jul 07

Movement Alert|Eli Lilly Rises 3.08% in Pre-Market Trading, Multiple Banks Raise Target Prices as Mounjaro Gains Pediatric Approval in Canada

Market Focus
·
Jul 07

Health Canada approves Eli Lilly’s Mounjaro for use in children 10 years old

TIPRANKS
·
Jul 07

Eli Lilly Canada - Health Canada Approves Mounjaro® (tirzepatide) for Use in Children 10 Years and Older Living with Type 2 Diabetes

THOMSON REUTERS
·
Jul 07

Eli Lilly Poised for Strong Quarterly Results as JPMorgan Lifts Price Target

Deep News
·
Jul 07

Transcenta Holding - to Revert Assets to Lilly for US$4 Mln Cash

THOMSON REUTERS
·
Jul 07